ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,589, issued on Jan. 13, was assigned to CalciMedica Inc. (La Jolla, Calif.).
"Synthesis of CRAC channel inhibitors" was invented by Kenneth Stauderman (San Diego), Michael Dunn (La Jolla, Calif.) and Kay Olmstead (San Diego).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is an improved synthetic method for the production of CRAC channel inhibitors. The synthetic method provides a method for producing highly pure CRAC channel inhibitors for clinical testing."
The patent was filed on Nov. 13, 2020, under Application No. 18/252,695.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/neta...